Detalhe da pesquisa
1.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Blood
; 141(21): 2615-2628, 2023 05 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36735903
2.
CT Extracellular Volume Fraction versus Myocardium-to-Lumen Signal Ratio for Cardiac Amyloidosis.
Radiology
; 306(3): e220542, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36255307
3.
Progression signature underlies clonal evolution and dissemination of multiple myeloma.
Blood
; 137(17): 2360-2372, 2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33150374
4.
Water Droplet-in-Oil Digestion Method for Single-Cell Proteomics.
Anal Chem
; 94(29): 10329-10336, 2022 07 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35817413
5.
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.
Biochem Biophys Res Commun
; 587: 153-159, 2022 01 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34875534
6.
[The role of regulatory T cells in multiple myeloma progression].
Rinsho Ketsueki
; 62(4): 299-304, 2021.
Artigo
Japonês
| MEDLINE | ID: mdl-33967155
7.
[Intravenous immunoglobulin in combination with ibrutinib for the treatment of IgM-type M protein associated peripheral neuropathy complicated with chronic lymphocytic leukemia].
Rinsho Ketsueki
; 62(3): 196-199, 2021.
Artigo
Japonês
| MEDLINE | ID: mdl-33828015
8.
Targeting the bone marrow microenvironment in multiple myeloma.
Immunol Rev
; 263(1): 160-72, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25510276
9.
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
Rinsho Ketsueki
; 60(10): 1443-1448, 2019.
Artigo
Japonês
| MEDLINE | ID: mdl-31695005
10.
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells.
Biochem Biophys Res Commun
; 507(1-4): 246-252, 2018 12 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30420285
11.
Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.
Blood
; 127(21): 2598-606, 2016 05 26.
Artigo
Inglês
| MEDLINE | ID: mdl-26903547
12.
[Successful diagnosis of lymphoplasmacytic lymphoma with IgG paraprotein using MYD88 L265P mutation analysis].
Rinsho Ketsueki
; 59(6): 695-697, 2018.
Artigo
Japonês
| MEDLINE | ID: mdl-29973445
13.
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.
Br J Haematol
; 198(3): e38-e41, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35524546
14.
A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.
Am J Hematol
; 92(8): E138-E145, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28474779
15.
Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study.
Jpn J Clin Oncol
; 52(12): 1446-1449, 2022 12 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36073950
16.
Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.
Curr Osteoporos Rep
; 15(5): 499-506, 2017 10.
Artigo
Inglês
| MEDLINE | ID: mdl-28889371
17.
Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma.
Curr Opin Hematol
; 23(4): 426-33, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27101529
18.
Targeting the Bone Marrow Microenvironment.
Cancer Treat Res
; 169: 63-102, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27696259
19.
Epigenetics in Multiple Myeloma.
Cancer Treat Res
; 169: 35-49, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27696257
20.
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.
Blood
; 121(6): 962-70, 2013 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-23212521